Search Results for: search.php

The non-invasive, acute or short-time preventive allergy treatment will be administered as aerosol spray, eye drops, or encapsulated for oral administration, ideally before exposure to the allergen. A complex of antibodies directed against pollen/food allergens with a cell-surface molecule prevents allergic inflammation by trappi ng the allergens on the
mucosal surface of the respi ratory tract, the eyes, or the gut.

Tue present invention relates to the generation and use of self-standing giant porous hydrophilic nanomembranes (PHNM). Currently available nanomembranes are mainly hydrophobic, which greatly limits their application in biotechnology and life sciences. In contrast, the PHNM is made from hydrophilic polymers and is therefore ideally suited for use inaqueous media.

Novel chromatic phase plate designed for STED or RESOLFT fluorescence light microscopy

This innovation allows to extract indispensable chemical resources out of renewable resources instead of mineral oil, the finite resource. It is a method for the degradation of terpenes by ethenolysis.

A new class of molecules with bifunctional properties can influence cortical neuron growth, with the potential for slowing or even reversing neuronal degeneration in Parkinson's patients.

The major clinical challenge in treating NPM-ALK+ anaplastic large cell
lymphomas (ALCL) is its high rate of relapse. Researchers of the Medical
University of Vienna identified high expression of PDGFRß in the NPMALK
induced ALCL. Pharmaceutical targeting of PDGFRB using a tyrosine
kinase inhibitor (TKI) strongly reduced tumor size in SCID-mice xenografted with NPM-ALK mouse tumor cells, and increased the survival of NPM-ALK+ transgenic mice by more than 90%. These data provide evidence for the use of FDA approved tyrosine kinase inhibitors for the effective treatment of lymphomas and encourage the development of specific clinical trials.